Healthlinx (ASX:HTX) is pursuing a transaction that subject to relevant regulatory and shareholder approvals would change its activities from biotechnology to a technology business focussed in the mobile gaming space.
Implementation of the transaction will require the company to undertake a substantial capital raising.
To assist with implementation of this transaction and to provide ongoing working capital, Healthlinx has completed a private placement of shares priced at $0.079 each to raise $200,000.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.
